EMAMILTD.NS(EMAMILTD.NS)
EMAMILTD.NS
No analyst ratings available
No analyst price targets available for EMAMILTD.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $42.30B | $45.89B | $49.86B | $56.45B |
| Low | $41.56B | $42.42B | $47.49B | $53.76B |
| High | $43.48B | $48.52B | $52.01B | $58.88B |
| EBITDA Avg | $12.03B | $13.05B | $14.18B | $16.05B |
| Low | $11.82B | $12.06B | $13.50B | $15.29B |
| High | $12.36B | $13.80B | $14.79B | $16.74B |
| EBIT Avg | $10.77B | $11.68B | $12.69B | $14.37B |
| Low | $10.58B | $10.80B | $12.09B | $13.68B |
| High | $11.07B | $12.35B | $13.24B | $14.99B |
| Net Income Avg | $8.13B | $9.06B | $9.79B | $12.22B |
| Low | $6.56B | $7.81B | $9.18B | $11.47B |
| High | $8.86B | $11.31B | $10.33B | $12.91B |
| EPS Avg | $18.63 | $20.76 | $22.42 | $28.00 |
| Low | $15.02 | $17.88 | $21.03 | $26.27 |
| High | $20.30 | $25.92 | $23.67 | $29.57 |
| Analysts (Rev / EPS) | 15 / 16 | 22 / 18 | 16 / 9 | 11 / 8 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $9.68B | $12.35B | $10.64B | $11.65B |
| Low | $8.89B | $10.93B | $9.57B | $10.48B |
| High | $10.62B | $13.11B | $11.46B | $12.55B |
| EBITDA Avg | $2.75B | $3.51B | $3.02B | $3.31B |
| Low | $2.53B | $3.11B | $2.72B | $2.98B |
| High | $3.02B | $3.73B | $3.26B | $3.57B |
| EBIT Avg | $2.46B | $3.14B | $2.71B | $2.97B |
| Low | $2.26B | $2.78B | $2.44B | $2.67B |
| High | $2.70B | $3.34B | $2.92B | $3.20B |
| Net Income Avg | $1.60B | $2.18B | $1.92B | $2.01B |
| Low | $1.39B | $1.90B | $1.67B | $1.75B |
| High | $1.76B | $2.41B | $2.11B | $2.21B |
| EPS Avg | $3.65 | $5.00 | $4.40 | $4.60 |
| Low | $3.18 | $4.35 | $3.83 | $4.00 |
| High | $4.02 | $5.51 | $4.84 | $5.06 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 2 / 1 | 1 / 1 |